熱門資訊> 正文
阿尔托神经科学任命迈克尔·汉利为首席运营官
2024-05-21 20:21
- Alto Neuroscience (NYSE:ANRO) said it has appointed industry veteran Michael Hanley as chief operating officer.
- Hanley has over 25 years of leadership experience in the life sciences industry, and most recently served as chief commercial officer and chief business officer at Aeglea BioTherapeutics.
More on Alto Neuroscience
- Alto Neuroscience: Potential First-In-Class Approach To Targeting CNS Disorders
- Alto Neuroscience schizophrenia treatment shows good phase 1 results
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
